Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.22.2.2
Shareholders' Deficit (Tables)
 9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of activity related to non-vested shares
    Number of
Non-Vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2021     14,270,120     $ 0.14  
Granted     3,500,000       0.014  
Forfeited    
-
      
-
  
Shares vested     (800,000 )     (0.037 )
Non-vested, September 30, 2022     16,970,120     $ 0.119  

 
Schedule of stock option activities
    Number of
Options		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding, December 31, 2021     8,445,698     $ 0.40                         
Exercised    
-
      
-
      
-
      
-
  
Balance Outstanding, September 30, 2022     8,445,698     $ 0.40       3.69     $ 0  
Exercisable, September 30, 2022     8,445,698     $ 0.40       3.69     $ 0  

 
Schedule of warrant activities
    Number of
Warrants		     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic
Value		  
Balance Outstanding December 31, 2021     17,500,000     $ 0.05       4.67     $
     -
  
Granted     33,000,000       0.025      
-
      
-
  
Cancelled     (16,500,000 )     0.05      
-
      
-
  
Balance Outstanding September 30, 2022     34,000,000     $ 0.011       3.99     $
-
  
Exercisable, September 30, 2022     34,000,000     $ 0.011       3.99     $
-